Randomized Placebo-Controlled Trial of Cognitive Behavioral Therapy and Armodafinil for Insomnia After Cancer Treatment
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Purpose: Insomnia is a distressing and often persisting consequence of cancer. Although cognitive behavioral therapy for insomnia (CBT-I) is the treatment of choice in the general population, the use of CBT-I in patients with cancer is complicated, because it can result in transient but substantial increases in daytime sleepiness. In this study, we evaluated whether CBT-I, in combination with the wakefulness-promoting agent armodafinil (A), results in better insomnia treatment outcomes in cancer survivors than CBT-I alone. Patients and Methods: We report on a randomized trial of 96 cancer survivors (mean age, 56 years; female, 87.5%; breast cancer, 68%). The primary analyses examined whether ≥ one of the 7-week intervention conditions (ie, CBT-I, A, or both), when compared with a placebo capsule (P) group, produced significantly greater clinical gains. Insomnia was assessed by the Insomnia Severity Index and sleep quality by the Pittsburgh Sleep Quality Inventory. All patients received sleep hygiene instructions. Results: Analyses controlling for baseline differences showed that both the CBT-I plus A (P = .001) and CBT-I plus P (P = .010) groups had significantly greater reductions in insomnia severity postintervention than the P group, with effect sizes of 1.31 and 1.02, respectively. Similar improvements were seen for sleep quality. Gains on both measures persisted 3 months later. CBT-I plus A was not significantly different from CBT-I plus P (P = .421), and A alone was not significantly different from P alone (P = .584). Conclusion: CBT-I results in significant and durable improvements in insomnia and sleep quality. A did not significantly improve the efficacy of CBT-I or independently affect insomnia or sleep quality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Morin, C. M., Belleville, G., Bélanger, L., & Ivers, H. (2011) · Sleep · doi:10.1093/sleep/34.5.601 · Cited by 4,620
Insomnia and Its Treatment: Prevalence and Correlates
Mellinger, G. D. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790260019002 · Cited by 1,071 · cited 1×
“These prevalence rates are especially striking, considering most epidemiologic studies report approximately 30% of adults in the general population experience insomnia symptoms, and approximately 10% meet diagnostic criteria for an insomnia disorder.(9,10) Insomnia in cancer survivors is particularly troublesome, beca…”
BackgroundPalesh, O. G., Roscoe, J. A., Mustian, K. M., Roth, T., Savard, J., Ancoli-Israel, S., Heckler, C., Purnell, J. Q., Janelsins, M. C., & Morrow, G. R. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.5011 · Cited by 557
Self-citationThe Natural History of Insomnia: A Population-Based 3-Year Longitudinal Study
Morin, C. M., Bélanger, L., LeBlanc, M., Ivers, H., Savard, J., Espie, C. A., Mérette, C., Baillargeon, L., & Grégoire, J.-P. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.610 · Cited by 498
Medical and socio-professional impact of insomnia
Léger, D., Guilleminault, C., Bader, G., Lévy, E., & Paillard, M. (2002) · Sleep · doi:10.1093/sleep/25.6.621 · Cited by 468
Savard, M.-H., Savard, J., Simard, S., & Ivers, H. (2005) · Psycho-Oncology · doi:10.1002/pon.860 · Cited by 449
Self-citationPrevalence, Clinical Characteristics, and Risk Factors for Insomnia in the Context of Breast Cancer
Savard, J., Simard, S., Blanchet, J., Ivers, H., & Morin, C. M. (2001) · SLEEP · doi:10.1093/sleep/24.5.583 · Cited by 414
Espie, C. A., Fleming, L., Cassidy, J., Samuel, L., Taylor, L. M., White, C. A., Douglas, N. J., Engleman, H. M., Kelly, H.-L., & Paul, J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9006 · Cited by 383
Garland, S. N., Carlson, L. E., Stephens, A. J., Antle, M. C., Samuels, C., & Campbell, T. S. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.7265 · Cited by 329
Self-citationMulticenter, Randomized Controlled Trial of Yoga for Sleep Quality Among Cancer Survivors
Mustian, K. M., Sprod, L. K., Janelsins, M., Peppone, L. J., Palesh, O. G., Chandwani, K., Reddy, P. S., Melnik, M. K., Heckler, C., & Morrow, G. R. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.7707 · Cited by 282
Self-citationAdherence to cognitive behavioral therapy for insomnia: a systematic review
Matthews, E. E., Arnedt, J. T., McCarthy, M. S., Cuddihy, L. J., & Aloia, M. S. (2013) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2013.01.001 · Cited by 199 · cited 1×
“Although CBT-I is effective in treating insomnia, between 32% and 89% of patients treated with CBT-I do not consistently follow treatment recommendations.(17) One reason for this low adherence is the temporary daytime sleepiness and/or worsening of daytime function that accompany the sleep-restriction component of CBT…”
BackgroundPrevalence, Natural Course, and Risk Factors of Insomnia Comorbid With Cancer Over a 2-Month Period
Savard, J., Villa, J., Ivers, H., Simard, S., & Morin, C. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.6333 · Cited by 197
Self-citationRandomized trial of a cognitive-behavioral intervention for insomnia in breast cancer survivors
Epstein, D. R., & Dirksen, S. R. (2007) · Oncology nursing forum · doi:10.1188/07.onf.e51-e59 · Cited by 152
Matthews, E. E., Berger, A. M., Schmiege, S. J., Cook, P. F., McCarthy, M. S., Moore, C. M., & Aloia, M. S. (2014) · Oncology Nursing Forum · doi:10.1188/14.onf.41-03ap · Cited by 103
The relationship between insomnia and patient satisfaction with quality of life in cancer
Lis, C. G., Gupta, D., & Grutsch, J. F. (2008) · Supportive Care in Cancer · doi:10.1007/s00520-007-0314-z · Cited by 69
Cited by
Sleep disorders and cancer: State of the art and future perspectives
Mogavero, M. P., DelRosso, L. M., Fanfulla, F., Bruni, O., & Ferri, R. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2020.101409 · Cited by 321
Sleep Disorders in Cancer—A Systematic Review
Büttner-Teleagă, A., Kim, Y.-T., Osel, T., & Richter, K. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182111696 · Cited by 186
“, Journal of Clinical Oncology 2015; 33 (2): 165–171 [57] 96 Cancer patients with Insomnia PSQI; Insomnia Severity Index (ISI) T1—Baseline T2—Post-Treatment (7 weeks) T3—Follow-up (3 months) CBT-I + A & CBT-I + P: → CBT-I improves Insomnia Severity (ISI) → CBT-I improves Sleep Quality (PSQI) → Armodafinil no effect on…”
BackgroundEfficacy of cognitive behavioral therapy for insomnia in breast cancer: A meta-analysis
Ma, Y., Hall, D. L., Ngo, L. H., Liu, Q., Bain, P. A., & Yeh, G. Y. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2020.101376 · Cited by 151
Exercise interventions to improve sleep in cancer patients: a systematic review and meta-analysis
Mercier, J., Savard, J., & Bernard, P. (2017) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.11.001 · Cited by 103
Self-citationInsomnia in adult patients with cancer: ESMO Clinical Practice Guideline
Grassi, L., Zachariae, R., Caruso, R., Palagini, L., Campos-Ródenas, R., Riba, M. B., Lloyd-Williams, M., Kissane, D., Rodin, G., McFarland, D., et al. (2023) · ESMO Open · doi:10.1016/j.esmoop.2023.102047 · Cited by 96
Metadata
- Authors
- Roscoe, J. A., Garland, S. N., Heckler, C. E., Perlis, M. L., Peoples, A. R., Shayne, M., Savard, J., Daniels, N. P., & Morrow, G. R.
- Venue
- Journal of Clinical Oncology
- Published
- 2015-01-10
- Volume
- 33
- Issue
- 2
- Pages
- 165-171
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2162970252
- Cited by
- 50
- References
- 15
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.